NCT02783534 is a NA clinical trial of Verum acupuncture in Primary Dysmenorrhea, sponsored by Huazhong University of Science and Technology.

Who is sponsoring NCT02783534?

NCT02783534 is sponsored by Huazhong University of Science and Technology.

What drugs are being tested in NCT02783534?

Interventions in NCT02783534: Verum acupuncture, Sham acupuncture, Usual care.

What condition does NCT02783534 study?

NCT02783534 studies Primary Dysmenorrhea.

Is NCT02783534 still recruiting?

NCT02783534 is currently status unknown. Last updated 25 October 2019.

Last reviewed 2019-10-25 · How we verify

NCT02783534

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Manual Acupuncture for Primary Dysmenorrhea

Status unknown NA Last updated 25 October 2019

What this trial tests

NA trial testing Verum acupuncture in Primary Dysmenorrhea in 300 participants. Status unknown.

Timeline

2 August 2016

Primary endpoint
1 July 2021

1 July 2021

Quick facts

Lead sponsor	Huazhong University of Science and Technology
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	300
Start date	2 August 2016
Primary completion	1 July 2021
Estimated completion	1 July 2021
Sites	1 location across China

Drugs / interventions tested

Verum acupuncture
Sham acupuncture
Usual care

Conditions studied

Primary Dysmenorrhea — all drugs for Primary Dysmenorrhea →

Sponsor

Huazhong University of Science and Technology

Who can join

Adults 15 to 40, female only, with Primary Dysmenorrhea. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Primary dysmenorrhea (PD) is a common complaint in menstruating women. Although nonsteroidal anti-inflammatory drug is an effective treatment, there are concerns about serious adverse events. Complementary therapies, including acupuncture, are commonly used for PD. Acupuncture has a low risk of adverse effects, while the evidence for the effectiveness of acupuncture in treating PD is inconclusive. Deqi and psychological factors are core concepts in acupuncture theory, but they have been largely neglected in primary dysmenorrhea clinical reports. The objective of this trail is to assess the clinical efficacy of acupuncture in the prevention of PD and investigate what factors will affect the efficacy of acupuncture.The results of this trial will significantly add to the current body of evidence on the role of acupuncture for PD. If found to be effective and safe, acupuncture will be a valuable treatment option in the prevention of PD. In additional, results from this trial will identify what factors will affect the efficacy of acupuncture.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Manual acupuncture versus sham acupuncture and usual care for the prevention of primary dysmenorrhea (PD): study protocol for a randomized controlled trial.
Yu L, Liu S, Zheng C, Liu W, et al · · 2020 · cited 4× · PMID 32993752 · DOI 10.1186/s13063-020-04720-5

Verify or expand the search:

Other trials of Verum acupuncture

Trials testing the same drug.

NCT02765581 — Efficacy Study of Acupuncture in the Prevention of Migraine Without Aura · NA · completed
NCT02364167 — Acupuncture for Pain Control After Elective Caesarean Section · Phase 2, PHASE3 · completed

Other recruiting trials for Primary Dysmenorrhea

Currently open trials in the same condition.

NCT07409337 — Self-Acupressure for Primary Dysmenorrhea and Premenstrual Symptoms · NA · recruiting
NCT06995287 — Evaluation of the Analgesic Effect of Intramyometrial Botulinum Toxin Injection Via Hysteroscopy in Severe Primary Dysme · Phase 3 · recruiting
NCT07352982 — Transcutaneous Tibial Nerve Stimulation on Women With Primary Dysmenorrhea · NA · recruiting
NCT07239232 — "Knee Joint Position Sense and Dynamic Balance in Females With Primary Dysmenorrhea · recruiting
NCT07314021 — Primary Dysmenorrhea and Mobilization. · NA · active not recruiting

Other Huazhong University of Science and Technology trials

Trials by the same sponsor.

NCT07502027 — A Clinical Study of Iparomlimab and Tuvonralimab Combined With SOX Following Heterogeneous Radiotherapy as First-line Tr · Phase 4 · not yet recruiting
NCT07502014 — A Clinical Study of Iparomlimab and Tuvonralimab Combined With Fruquintinib and Heterogeneous Radiotherapy Versus Fruqui · Phase 2 · not yet recruiting
NCT07509866 — Liposomal Bupivacaine Versus Ropivacaine With Perineural Dexamethasone or Dexmedetomidine as Adjuncts for Adductor Canal · NA · recruiting
NCT07326943 — Minimum Effective Dose of Ropivacaine for Ultrasound-guided Interscalene Block · NA · recruiting
NCT07229976 — Clinical Efficacy of Thumbtack Needle for Chronic Insomnia in Perimenopausal and Menopausal Women · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02783534 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Huazhong University of Science and Technology
Last refreshed: 25 October 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02783534.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing